Vanda Pharmaceuticals
VNDA
#7861
Rank
NZ$0.55 B
Marketcap
NZ$9.33
Share price
3.65%
Change (1 day)
12.55%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -NZ$0.21 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.21 Billion. In 2024 the company made an earning of -NZ$70.39 Million a decrease over its 2023 earnings that were of -NZ$24.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.21 Billion195.18%
2024 -NZ$70.39 Million191.43%
2023 -NZ$24.16 Million-320.45%
2022 NZ$10.95 M-84.99%
2021 NZ$72.98 M54.8%
2020 NZ$47.15 M19.42%
2019 NZ$39.48 M4.93%
2018 NZ$37.62 M-228.6%
2017 -NZ$29.26 Million-8.98%
2016 -NZ$32.15 Million-53.79%
2015 -NZ$69.57 Million-30.18%
2014 -NZ$99.63 Million173.08%
2013 -NZ$36.49 Million-25.33%
2012 -NZ$48.86 Million163.61%
2011 -NZ$18.54 Million-221.15%
2010 NZ$15.29 M-124.53%
2009 -NZ$62.38 Million-29.44%
2008 -NZ$88.4 Million-36.2%
2007 -NZ$0.14 Billion21.81%
2006 -NZ$0.12 Billion170.55%
2005 -NZ$42.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$28.42 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$38.95 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.07 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.90 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.51 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-NZ$4.86 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.96 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA